olivlawolivlaw

olivLaw · European equity research

Acteos EOS.PA

France · Euronext Paris · ISIN FR0000076861 · Vertical: Listed companies from France

0.76EUR0.00% · 1 dayClose 05 Nov 2026

Acteos is a French supply chain software provider focused on logistics planning, warehouse management and transport optimisation. The company returned to a loss in fiscal 2021, with a net result of -859 K EUR, after growth and a return to profit in 2020, and it says it aims to return to profit from 2022.

At the close of 05 Nov 2026, Acteos (EOS.PA) stock was 0.76 EUR (+0.00% on the day), with market capitalisation 2.5 m EUR, beta 0.20, 52-week range 0.73–1.04 EUR.

Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.

Market cap
2.5 m EUR
shares as of 31 Dec 2021
P/E (TTM)
unavailable
Diluted EPS TTM -0.20 · TTM to 31 Dec 2021
E/P (TTM)
-26.32%
TTM to 31 Dec 2021
Dividend yield
unavailable
Beta (2y)
0.20
Volatility (1y) 38%
52-week range
0.731.04

Price history

Loading chart…

Technical reading

RSI (14)
39.9
weak (30–45)
Bollinger (20, 2)
0.74 – 0.83
in the lower half of the band · %B 0.22 · band width 11.9%
SMA 50 / 200
0.82 / 0.87
downtrend (price < SMA50 < SMA200)
MACD (12, 26, 9)
-0.02 / -0.02
MACD below signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyEURO STOXX 50vs EURO STOXX 50Vertical median
1 month−6.2%−0.6%−5.5 pp—
3 months−10.6%−4.2%−6.4 pp—
6 months−15.4%+4.3%−19.7 pp—
Year to date−22.3%+7.5%−29.8 pp—
1 year−23.2%+9.9%−33.2 pp−6.8%
3 years−41.5%+49.8%−91.4 pp−15.9%
5 years−67.7%+42.8%−110.5 pp—
Max drawdown (1y)
−29.5%
28 Nov 2025 → 02 Nov 2026
Max drawdown (5y)
−68.8%
08 Nov 2021 → 02 Nov 2026
Compound annual growth (5y)
−20.2%
EURO STOXX 50 +7.4%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Fiscal years

Fiscal year20202021
Revenue16.0 m13.0 m
Revenue YoYunavailable−18.9%
Net income159.6 k-735.4 k
Net income YoYunavailable−560.7%
Diluted EPS0.04-0.20
Diluted EPS YoYunavailable−600.0%
net %1.0%-5.7%
Free cash flow-31.0 k2.2 m

Balance sheet & financial health

Fiscal year 2021 · 31 Dec 2021

Cash
4.1 m EUR
Financial debt
4.9 m EUR
Net debt
799.7 k EUR
Equity
-250.5 k EUR
Total assets
15.9 m EUR
Debt / equity
unavailable
Current ratio
1.07x
ROE
unavailable
ROA
-4.1%
FCF margin
17.1%

Financial statements (source on every figure)

Revenue and net income (EUR)

Margins

Income statement · EUR

Revenue
2020
16.0 m
2021
13.0 m

esef· 29 Mar 2022verified

Gross profit
2020
8.7 m
2021
8.1 m

esef· 29 Mar 2022verified

Operating income
2020
206.0 k
2021
-898.5 k

esef· 29 Mar 2022verified

Depreciation & amortisation
2020
1.3 m
2021
1.2 m

esef· 29 Mar 2022verified

EBITDA
2020
1.5 m ≈
2021
345.6 k ≈

esef· 29 Mar 2022derived

Income tax
2020
-36.8 k
2021
3.9 k

esef· 29 Mar 2022verified

Net income
2020
159.6 k
2021
-735.4 k

esef· 29 Mar 2022verified

Diluted EPS
2020
0.04
2021
-0.20

esef· 29 Mar 2022verified

Balance sheet · EUR

Cash
2020
4.7 m
2021
4.1 m

esef· 29 Mar 2022verified

Inventories
2020
525.0 k
2021
390.5 k

esef· 29 Mar 2022verified

Current assets
2020
14.2 m
2021
10.8 m

esef· 29 Mar 2022verified

Property, plant & equipment, net
2020
1.4 m
2021
1.4 m

esef· 29 Mar 2022verified

Goodwill
2020
594.5 k
2021
594.5 k

esef· 29 Mar 2022verified

Intangibles (excl. goodwill)
2020
2.6 m
2021
2.4 m

esef· 29 Mar 2022verified

Total assets
2020
19.7 m
2021
15.9 m

esef· 29 Mar 2022verified

Long-term debt
2020
6.0 m
2021
4.9 m

esef· 29 Mar 2022verified

Current liabilities
2020
11.9 m
2021
10.1 m

esef· 29 Mar 2022verified

Equity
2020
409.7 k
2021
-250.5 k

esef· 29 Mar 2022verified

Shares outstanding at year end
2020
4.0 m
2021
3.3 m

esef· 29 Mar 2022derived

Cash flow · EUR

Operating cash flow
2020
10.4 k
2021
2.3 m

esef· 29 Mar 2022verified

Capex
2020
41.4 k
2021
66.5 k

esef· 29 Mar 2022verified

Free cash flow
2020
-31.0 k ≈
2021
2.2 m ≈

esef· 29 Mar 2022derived

Investing cash flow
2020
-987.7 k
2021
-796.0 k

esef· 29 Mar 2022verified

Financing cash flow
2020
4.8 m
2021
-2.2 m

esef· 29 Mar 2022verified

Computed indicators

Growth

Revenue growth (YoY)
-18.9%
computed by olivLawFY 2021
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
-536.1%
computed by olivLawFY 2021
Net income growth (YoY)
-560.7%
computed by olivLawFY 2021
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
-600.0%
computed by olivLawFY 2021
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
unavailable
the base of the ratio is not positive

Profitability

Gross margin
62.6%
computed by olivLawFY 2021
EBITDA margin
2.7%
computed by olivLawFY 2021
EBIT margin
-6.9%
computed by olivLawFY 2021
Net margin
-5.7%
computed by olivLawFY 2021
FCF margin
17.1%
computed by olivLawFY 2021

Returns

ROE
-923.7%
computed by olivLawFY 2021 · balance sheet at 31 Dec 2021
ROA
-4.1%
computed by olivLawFY 2021 · balance sheet at 31 Dec 2021
ROIC
unavailable
equity is negative: buybacks shrink the invested capital and ROIC would come out large without meaning anything
ROCE
-15.4%
computed by olivLawFY 2021 · balance sheet at 31 Dec 2021
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
unavailable
input data missing

Balance sheet

Net debt
799.7 k EUR
computed by olivLawbalance sheet at 31 Dec 2021
Net debt / EBITDA
2.3x
computed by olivLawFY 2021 · balance sheet at 31 Dec 2021
Debt / equity
unavailable
equity is negative: the ratio is not economically meaningful (not by itself insolvency; usually the result of buybacks)
Interest coverage
unavailable
input data missing

Liquidity

Current ratio
1.1x
computed by olivLawbalance sheet at 31 Dec 2021
Quick ratio
1.0x
computed by olivLawbalance sheet at 31 Dec 2021
Cash ratio
0.4x
computed by olivLawbalance sheet at 31 Dec 2021

Cash

Operating cash flow
2.3 m EUR
computed by olivLawFY 2021
Capital expenditure
66.5 k EUR
computed by olivLawFY 2021
Free cash flow
2.2 m EUR
computed by olivLawFY 2021
FCF conversion
unavailable
insufficient data
Cash conversion
660.2%
computed by olivLawFY 2021

Efficiency

Days sales outstanding
unavailable
input data missing
Days inventory outstanding
unavailable
input data missing
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
2.5 m EUR
computed by olivLawbalance sheet at 31 Dec 2021
Enterprise value
3.3 m EUR
computed by olivLawbalance sheet at 31 Dec 2021
Market cap / net income TTM
unavailable
insufficient data
P/E (TTM)
unavailable
insufficient data
Earnings yield
-26.3%
computed by olivLawFY 2021
P/B
unavailable
equity is negative: the ratio is not economically meaningful (not by itself insolvency; usually the result of buybacks)
P/S
0.2x
computed by olivLawFY 2021 · balance sheet at 31 Dec 2021
EV/EBITDA
9.7x
computed by olivLawFY 2021 · balance sheet at 31 Dec 2021
EV/EBIT
unavailable
insufficient data
EV/Sales
0.3x
computed by olivLawFY 2021 · balance sheet at 31 Dec 2021
P/FCF
1.1x
computed by olivLawFY 2021 · balance sheet at 31 Dec 2021
FCF yield
87.2%
computed by olivLawFY 2021 · balance sheet at 31 Dec 2021
Dividend yield
unavailable
no dividend in the structured statements; a missing line is not a confirmed zero
Shareholder yield (distributions)
unavailable
input data missing

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • indicators available: 5 of at least 6
  • score weight coverage: 39.6% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

0.76 EUR

05 Nov 2026Source: olivLaw, closing series

Market cap: 2.5 m EUR

Key indicators

Market capitalisation
2.5 m EUR
computed by olivLawbalance sheet at 31 Dec 2021
P/E (TTM)
unavailable
insufficient data
P/B
unavailable
equity is negative: the ratio is not economically meaningful (not by itself insolvency; usually the result of buybacks)
EV/EBITDA
9.7x
computed by olivLawFY 2021 · balance sheet at 31 Dec 2021
ROE
-923.7%
computed by olivLawFY 2021 · balance sheet at 31 Dec 2021
Net margin
-5.7%
computed by olivLawFY 2021
Revenue growth (YoY)
-18.9%
computed by olivLawFY 2021
Dividend yield
unavailable
no dividend in the structured statements; a missing line is not a confirmed zero

Coverage and freshness

24/37 reporting lines present
Latest full fiscal year: 2021
Latest reported period: 31 Dec 2021
Latest balance sheet date: 31 Dec 2021
Share count (cover of the latest filing), as of: 31 Dec 2021
Source: esefpublished 29 Mar 2022
verified 47derived 2

The data is older than the freshness threshold.

Score by group

40% · Insufficient data

Estimated value range

Low
0.40
EUR per share
Mid
0.57
EUR per share
High
0.90
EUR per share
Price: 0.76 EUR
The price is within the range
Potential to the central value: -24.6% (value / price − 1)
Margin of safety: -32.6% (1 − price / value)
Agreement between methods: single method · 1 methods used · 1 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 0.40 – 0.90 EUR.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (EUR per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)unavailable · input data missing
  • Peers: EV/EBITDA0.40 – 0.90 (Mid 0.57)
    4 companies used · median multiple 7.9x · quartiles 6.2x – 11.0x
    ABEO.PA, AI.PA, ANTIN.PA, ATE.PA
  • Peers: P/Eunavailable · the base of the ratio is not positive
  • Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption

Assumptions (illustrative, editorial)

Risk-free rate
3.0%
Equity risk premium
5.5%
Beta (default)
1.00
Cost of equity
8.5%
Terminal growth
2.0%

Factor scorecard

Insufficient data

Minimum-evidence gate: indicators available: 5 of at least 6; score weight coverage: 39.6% of at least 60%

FactorValueScoreWeight used
ROIC · Qualityunavailableunavailable—
Net margin · Quality-5.7%31 (vs peers)16%
FCF conversion · Qualityunavailableunavailable—
Revenue CAGR 3Y · Growthunavailableunavailable—
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheet2.3x29 (vs peers)26%
Interest coverage · Balance sheetunavailableunavailable—
Current ratio · Balance sheet1.1x23 (on a fixed band)11%
P/E (TTM) · Valuationunavailableunavailable—
EV/EBITDA · Valuation9.7x20 (vs peers)26%
FCF yield · Valuation87.2%100 (on a fixed band)21%
Shareholder yield (distributions) · Returnsunavailableunavailable—
Payout ratio (FCF) · Returnsunavailableunavailable—

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet27/100 · 2/3 factors with a value
  • Growth· partialunavailable · 0/2 factors with a value
  • Quality· partial31/100 · 1/3 factors with a value
  • Returns· partialunavailable · 0/2 factors with a value
  • Valuation56/100 · 2/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

ACTEOS (EOS.PA). Latest full fiscal year: 2021; data up to 2021-12-31.

Figures computed from the financial statements: revenue 13.0 m EUR in 2021; YoY growth -18.9%; net margin -5.7%; ROE -923.7%; net debt/EBITDA 2.3x.

The estimated value range is 0.40–0.90 EUR per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 0.57 EUR, the price of 0.76 EUR leaves a potential of -24.6% (value / price − 1) and a margin of safety of -32.6% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

Insufficient data for a verdict (indicators available: 5 of at least 6; score weight coverage: 39.6% of at least 60%).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • FCF yield: 87.2%

What contradicts it

  • Net debt / EBITDA: 2.3x
  • Current ratio: 1.1x
  • EV/EBITDA: 9.7x

Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Interest coverage, P/E (TTM), Shareholder yield (distributions), Payout ratio (FCF).

Versus the vertical median

Listed companies from France · same country · compared with 39 companies

Multiples and returns vs the median

P/E
—
vertical median 18.3x
EV/EBITDA
9.7x
vertical median 6.3x
above median (+54.6%)
P/S
0.2x
vertical median 0.5x
below median (−61.7%)
P/B
—
vertical median 1.1x
ROE
-923.7%
vertical median 4.2%
below median (−22,333.1%)
Net margin
-5.7%
vertical median 1.1%
below median (−603.5%)
EBIT margin
-6.9%
vertical median 3.2%
below median (−318.3%)
Revenue YoY
-18.9%
vertical median 0.6%
below median (−3,309.9%)
Net debt/EBITDA
2.3x
vertical median -1.2x
above median
Dividend yield
—
vertical median 1.7%

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
AI.PAL'air Liquide Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude109.3 bn33.212.9%12.2%−2.0%+26% / +32%
AC.PAAccor13.8 bn30.79.6%8.0%+0.6%+6% / +56%
ADP.PAAeroports De Paris11.7 bn34.17.8%5.6%+12.1%−7% / +4%
AKE.PAArkema7.1 bn115.40.9%0.7%−5.0%+12% / −37%
ALO.PAAlstom5.8 bn18.33.1%1.7%+3.7%−51% / −4%
AF.PAAir France - Klm4.3 bn13.6—1.0%+4.8%+20% / +9%
ATE.PAAlten3.1 bn29.54.8%2.6%−1.1%+33% / −29%
BB.PASociete Bic2.7 bn31.35.0%4.1%−4.8%+32% / +5%
ANTIN.PAAntin Infrastructure Partners1.4 bn13.021.9%36.6%−8.1%−24% / −35%
74SW.PA74software792.7 m20.98.9%8.5%+44.8%−13% / +41%
AUB.PAAubay667.4 m17.813.6%6.3%+11.3%+3% / +45%
ASY.PAAssystem507.1 m69.92.5%1.1%+7.4%−19% / −18%
ATO.PAAtos Se483.0 m—-23,400.0%-17.5%−16.5%−45% / −94%
ARAMI.PAAramis Group298.8 m15.010.0%0.8%+6.3%−33% / −16%
ARVEN.PAArverne Group246.1 m—-14.0%-115.3%+27.0%+20% / −35%
BGO.PACompagnie Chargeurs Invest189.4 m—-8.6%-5.7%−2.9%unavailable / unavailable
ALCIS.PACatering International & Services145.0 m28.49.3%1.9%+5.8%+39% / +107%
ALCGM.PACegedim144.6 m—-2.6%-1.2%+10.9%−26% / −49%
ATEME.PAAteme144.0 m151.32.8%1.0%+2.2%+82% / +77%
ALHEX.PAHexaom144.0 m6.79.9%2.2%+13.1%−32% / +7%
ALBON.PACompagnie Lebon111.7 m16.54.2%8.8%−17.9%+6% / +8%
ALHYF.PALhyfe75.8 m—-33.4%-570.5%+287.2%unavailable / unavailable
ALFER.PASergeferrari Group61.5 m11.55.1%1.5%+7.4%−33% / −27%
ABEO.PAAbeo60.8 m7.36.9%3.0%+12.6%−13% / −54%
ABNX.PAAbionyx Pharma53.5 m—-92.3%-136.6%−10.7%−62% / +19%

1- and 3-year price returns: for EOS.PA from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (EUR)

Estimated priceBearBaseBull
1 years
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
3 years
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
5 years
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
What moves the 3-year price the most

    AI analysis

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    In brief

    Acteos is a French supply chain software provider focused on logistics planning, warehouse management and transport optimisation. The company returned to a loss in fiscal 2021, with a net result of -859 K EUR 1, after growth and a return to profit in 2020, and it says it aims to return to profit from 2022.

    SWOT

    Strengths

    • The integrated Acteos SCM suite covers procurement, warehouse and transport in one product, and the company has its own calculation engines 1.
    • The R&D team works with leading European universities and has been recognised several times, supporting its technology reputation 1.
    • A history of more than thirty years and relationships with banks helped the firm through a difficult period 1.

    Weaknesses

    • The company reported a net loss in 2021 and a negative EBIT, after a year of return to profitability 1.
    • Shareholders' equity has deteriorated because of repeated losses, which may affect the confidence of clients and suppliers 1.
    • Working capital management is sensitive, and large orders can cause significant swings in cash 1.

    Opportunities

    • A recovery of supply chain tenders could revive client investment if the trend continues 1.
    • Predictive analytics and big data open room for new products such as Acteos BI & Analytics 1.
    • A recurring revenue model through maintenance and SaaS contracts could stabilise revenue 1.

    Threats

    • Economic uncertainty and the conflict in Ukraine could postpone client investment in supply chain 1.
    • Dynamic competition could overtake the firm's products if R&D investment slows 1.
    • Exposure to the US dollar, through the Lebanese subsidiary and US suppliers, can create currency losses 1.

    Risks

    • Repeated operating losseshigh

      Losses in recent years have reduced equity, and the company may need clear evidence of a return to profit to keep partners' confidence 1.

    • Liquidity and working capital riskmedium

      Working capital swings can be large, and cash tensions may appear in the second half of the year, although banking facilities are available but unused 1.

    • Goodwill impairment riskmedium

      If subsidiary performance falls, the company could be required to record partial or full impairment of goodwill or investments 1.

    • Currency riskmedium

      A significant part of flows is in dollars, and an unfavourable currency move could affect margins, although the company has hedged part of the exposure 1.

    • Technology riskhigh

      A lack of R&D investment could make products obsolete quickly against competitors, which could affect long-term sales 1.

    Investment thesis

    What would need to be true (bull case)

    • If the recovery in supply chain tenders is confirmed, Acteos could return to profit faster than management has announced, using its integrated suite.
    • The technological profile of the products and the recurring revenue model through maintenance and SaaS could support steadier growth.
    • Development of predictive analytics and business intelligence products could open new markets for existing clients.

    What would break the thesis

    • Repeated losses and shrinking equity could make clients and banks more cautious about new contracts.
    • Economic uncertainty and the conflict in Ukraine could prolong the postponement of supply chain client investment.
    • The constant R&D effort could remain hard to fund if the return to profit is delayed.

    What to watch

    • Return to profitability announced by management, with a positive net result2022
    • Development of consolidated shareholders' equity after the 2021 loss2022
    • Level of orders from supply chain tenders after the recovery from September 20212022
    • Effects of the Ukraine conflict on clients and on the dollar exchange rate2022

    Products, market & competition

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    The business

    The Acteos group develops and sells the modular, integrated Acteos SCM suite, covering multi-level procurement management and optimisation, warehouse management and transport optimisation 1. The company presents itself as a forerunner in real-time steering of supply chain flows and bases its model on technological and organisational innovation 1. R&D spending in fiscal 2021 was 1,038 K EUR gross, or 8.0% of consolidated revenue 1.

    Segments

    Acteos SCM suite (WMS, TMS, FPS)

    The software includes WMS for warehouses, TMS for transport and FPS, plus in-house engines for forecasting, route optimisation and dynamic resource planning 1. In 2021 the company worked on a mobile application for transport and warehouse and on a multi-level forecasting engine based on machine learning 1.

    Business intelligence and predictive analytics

    Acteos developed Acteos BI & Analytics for the supply chain so that clients can exploit their data and track logistics KPIs 1. The company links this product to the trend towards predictive analytics and big data, which is reshaping traditional business intelligence systems 1.

    Market context

    The company says that from September 2021 the exit from the Covid-19 crisis was visible in a strong recovery of tender phases in the supply chain market 1. Its products are usually significant investments for clients, who in periods of uncertainty tend to reduce, defer or cancel spending, which can hit annual orders and revenue 1. Acteos mainly invoices in euros, but part of its flows are in dollars, linked to its Lebanese subsidiary and US suppliers 1.

    The sources do not give the size of the global supply chain software market. Views on demand rest on the company's own statements about tenders and client investment 1.

    Trends

    • Demand recovery after the pandemictailwind

      The company notes a resumption of tenders in the supply chain market from September 2021, which could support orders if the trend holds 1.

    • Geopolitical uncertainty after the war in Ukraineheadwind

      The conflict that began in February 2022 could have macroeconomic effects that are not yet clear, and a slowdown in global activity could weigh on supply chain clients 1.

    • Digitalisation and predictive analyticsmixed

      Demand for predictive analytics, big data and machine learning could create openings for advanced software, but it requires continuous R&D investment 1.

    • High cost of innovationheadwind

      The company says development effort cannot be slowed without risking being overtaken by competitors, yet the investment weighs on financial balance 1.

    Competitive position

    The document describes a dynamic competitive market and says Acteos hopes to differentiate through technological lead and a complete product range 1. No specific competitors are named in the sources provided.

    • Unnamed supply chain software vendors

      The source only states the market is competitive and dynamic; no firms are identified.

    • Other logistics software providers

      The company refers to its competitors generically, without names, in the context of technological lead.

    • Business intelligence providers for supply chain

      The company implicitly compares its solutions with traditional business intelligence systems, without naming firms.

    • Logistics solution integrators

      The company argues isolated solutions cannot optimise processes globally, positioning its integrated suite as an alternative.

    News & filings

    In the press

    No news in our archive over the last 180 days.

    Annual reports (ESEF)

    Sources

    1. [1] Annual report, fiscal year ended 2021-12-31 (ESEF) · SEC / Acteos · 31 Dec 2021

    Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.

    Acteos (EOS.PA): stock, results, valuation and forecast · olivLaw